课题基金 / 基金详情

PATHOGENESIS OF NEONATAL NECROTIZING ENTEROCOLITIS

PATHOGENESIS OF NEONATAL NECROTIZING ENTEROCOLITIS
新生儿坏死性小肠结肠炎的发病机制
批准号:
2202117
负责人:
PINAKI PANIGRAHI
金额:
$9.66万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-04-01 至 1999-03-31

项目摘要

项目成果

PINAKI PANIGRAHI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (adapted from investigator's abstract and/or aims): The overall objective of this FIRST award application is to test the hypothesis that patterns of bacterial colonization and adherence in the bowel play a role in determining whether newborns develop NEC. The proposed work represents an extension of the following observations by the applicant: 1) endemic NEC cannot be attributed to a single infectious agent, 2) Escherichia coli (E. coli) strains isolated from NEC cases and controls that exhibit a high degree of adherence to intestinal epithelia in-vitro and in-vivo also cause cell injury, and 3) the adherence and cell injury elicited by these bacteria are blocked by co-infection with selected strains of Enterococci from control infants while Enterococci from NEC cases had no such effect. In this application, studies are proposed to determine what mechanisms are responsible for the adherence of the E. coli test strain to intestinal epithelia. Antisera directed against specific adhesions on E. coli as well as non-adherent isogeneic mutants of the strain will be used to define the adhesion molecule that allows for bacterial adherence to intestinal cells and the influence of different environmental factors relevant to NEC on bacterial adherence. Another series of experiments will attempt to determine how Enterococci from control infants block the adherence of E. coli to intestinal epithelia. The third component of this project will focus on host responses to bacteria-epithelial cell adhesion, with particular attention devoted to changes in tumor necrosis factor (TNF) elicited by adherent bacteria. Finally, studies will be performed to determine whether anti-inflammatory agents such as superoxide dismutase (SOD), misoprostol, and dexamethasone attenuate the tissue necrosis caused by adherent bacteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prevention of neonatal infection in the Indian community setting using probiotics
  • 批准号:
    7628537
  • 项目类别:
  • 资助金额:
    $44.64万
  • 财政年份:
    2007
  • 负责人:
    PINAKI PANIGRAHI
  • 依托单位:
Prevention of neonatal infection in the Indian community setting using probiotics
  • 批准号:
    7260679
  • 项目类别:
  • 资助金额:
    $48.71万
  • 财政年份:
    2007
  • 负责人:
    PINAKI PANIGRAHI
  • 依托单位:
Prevention of neonatal infection in the Indian community setting using probiotics
Prevention of neonatal infection in the Indian community setting using probiotics
国内基金
海外基金
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
  • 批准号:
    32302245
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    潘寒姁
  • 依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
  • 批准号:
    82371775
  • 项目类别:
    面上项目
  • 资助金额:
    46万元
  • 批准年份:
    2023
  • 负责人:
    朱慧媛
  • 依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
  • 批准号:
    31871817
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2018
  • 负责人:
    孙爱东
  • 依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
  • 批准号:
    81873549
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    刘玉兰
  • 依托单位: